Literature DB >> 7523295

Lymphocyte proliferation in response to immunodominant antigens of Brucella abortus 2308 and RB51 in strain 2308-infected cattle.

M G Stevens1, S C Olsen, N F Cheville.   

Abstract

Lymphocyte proliferation in response to proteins from the Brucella abortus strain 2308 (S2308) and the lipopolysaccharide (LPS) O-antigen-deficient mutant of S2308, strain RB51 (SRB51), was measured in S2308-infected cattle following abortion. Supramammary and superficial cervical lymph node lymphocytes from infected cattle proliferated most when incubated with 27- to 18-kDa proteins of S2308 or SRB51. Proteins of SRB51, which contained no LPS O antigens, induced lymphocyte proliferation similar to that induced by S2308 proteins, which contained LPS O antigens. These results indicate that 27- to 18-kDa proteins, but not LPS O antigens, of S2308 and SRB51 are immunodominant in S2308-infected cattle as assessed by lymphocyte proliferation assays.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523295      PMCID: PMC303157          DOI: 10.1128/iai.62.10.4646-4649.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting.

Authors:  B M Brooks-Worrell; G A Splitter
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Sodium dodecyl sulfate- and salt-extracted antigens from various Brucella species induce proliferation of bovine lymphocytes.

Authors:  B M Brooks-Worrell; G A Splitter
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  Induction of lymphocyte responsiveness by the outer membrane-peptidoglycan complex of rough strains of Brucella abortus.

Authors:  R Smith; L G Adams; B A Sowa; T A Ficht
Journal:  Vet Immunol Immunopathol       Date:  1990-09       Impact factor: 2.046

4.  Persistence of Brucella abortus infection in six herds of cattle under brucellosis eradication.

Authors:  D O Cordes; M E Carter
Journal:  N Z Vet J       Date:  1979-12       Impact factor: 1.628

5.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

6.  Isolation of Brucella abortus ssb and uvrA genes from a genomic library by use of lymphocytes as probes.

Authors:  Y Zhu; S C Oliveira; G A Splitter
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Determination of bovine lymphocyte responses to extracted proteins of Brucella abortus by using protein immunoblotting.

Authors:  B Brooks-Alder; G A Splitter
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

Review 8.  Human brucellosis.

Authors:  E J Young
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

9.  Outer membrane proteins of Brucella abortus: isolation and characterization.

Authors:  D R Verstreate; M T Creasy; N T Caveney; C L Baldwin; M W Blab; A J Winter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex.

Authors:  G G Schurig; C Hammerberg; B R Finkler
Journal:  Am J Vet Res       Date:  1984-05       Impact factor: 1.156

View more
  12 in total

1.  Lymphocyte proliferative responses of goats vaccinated with Brucella melitensis 16M or a delta purE201 strain.

Authors:  S C Olsen; N F Cheville; M G Stevens; H H Houng; E S Drazek; T L Hadfield; R L Warren; D L Hoover
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.

Authors:  M G Stevens; S C Olsen; M V Palmer; G W Pugh
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19.

Authors:  M G Stevens; S C Olsen; G W Pugh
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

4.  Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis.

Authors:  O L Rossetti; A I Arese; M L Boschiroli; S L Cravero
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  Deletion of purE attenuates Brucella melitensis infection in mice.

Authors:  R M Crawford; L Van De Verg; L Yuan; T L Hadfield; R L Warren; E S Drazek; H H Houng; C Hammack; K Sasala; T Polsinelli; J Thompson; D L Hoover
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle.

Authors:  P A Denoel; T K Vo; A Tibor; V E Weynants; J M Trunde; G Dubray; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh; D Brees
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Lymphocyte proliferation in response to Brucella abortus RB51 and 2308 proteins in RB51-vaccinated or 2308-infected cattle.

Authors:  M G Stevens; S C Olsen; N F Cheville
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51.

Authors:  M G Stevens; S C Olsen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.